ERAS in Totally Laparoscopic Total Gastrectomy for Gastric Cancer

NCT06489288 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2656

Last updated 2024-07-05

No results posted yet for this study

Summary

The number of totally laparoscopic total gastrectomy is gradually increasing, but the safety of ERAS in these term is still unknown and further multicenter randomized controlled studies are needed.

Conditions

Interventions

OTHER

ERAS protocol

The ERAS process mainly includes removing the urethral catheter before the recovery of anesthesia, removing the abdominal drainage tube within 3 days after surgery, removing the nasogastric feeding tu

Sponsors & Collaborators

  • First Hospital of China Medical University

    collaborator OTHER
  • First Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER
  • Peking University Cancer Hospital & Institute

    collaborator OTHER
  • Tongji Hospital

    collaborator OTHER
  • General Hospital of Ningxia Medical University

    collaborator OTHER
  • Second Affiliated Hospital of Suzhou University

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER
  • Nanfang Hospital, Southern Medical University

    collaborator OTHER
  • Gansu Provincial Hospital

    collaborator OTHER
  • Fudan University

    collaborator OTHER
  • Changzhi People's Hospital

    collaborator OTHER
  • Zhejiang University

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • The Second Affiliated Hospital of Shandong First Medical University

    collaborator OTHER
  • Guangdong Provincial People's Hospital

    collaborator OTHER
  • Xijing Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-05-01
Completion
2025-12-01

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06489288 on ClinicalTrials.gov